【前列腺癌】使用ML預測「TZ PCa」患者的生化無復發生存期(BRFS)和總體生存期(OS)

 【前列腺癌】使用ML預測「TZ PCa」患者的生化無復發生存期(BRFS)和總體生存期(OS)

 文章出處  

Frontiers in Endocrinology 

 

 原文標題  

TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models 

 

 文章序號  

7612 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.